Strontium Ranelate (CAS 135459-90-4) is a vital pharmaceutical compound, and its stability over time is crucial for patient safety and treatment efficacy. Ensuring this stability requires sophisticated analytical techniques, with Ultra-Performance Liquid Chromatography (UPLC) emerging as a cornerstone in stability testing protocols.

As a leading manufacturer and supplier of pharmaceutical intermediates in China, we employ validated UPLC methods to meticulously assess the stability of Strontium Ranelate under various stress conditions. These conditions, including thermal, photolytic, hydrolytic, and oxidative challenges, mimic real-world scenarios that the drug might encounter during its lifecycle.

The UPLC method allows for the separation and quantification of Strontium Ranelate from any degradation products that may form. Its high resolution and speed enable rapid analysis, providing crucial data on how the compound behaves over time. This information is indispensable for determining appropriate storage conditions, packaging, and ultimately, the shelf-life of the drug product.

Our expertise in developing and validating these UPLC methods means that when you choose to buy Strontium Ranelate from us, you are assured of a product that has undergone rigorous stability assessment. We provide our partners with comprehensive data, supporting their own quality control and regulatory submissions. The ability to accurately identify and quantify degradation products through UPLC is a key differentiator for pharmaceutical manufacturers prioritizing product integrity.

For any organization looking to source Strontium Ranelate with guaranteed stability, our company stands as a trusted supplier. Our commitment to employing advanced analytical tools like UPLC underscores our dedication to delivering APIs that meet the highest pharmaceutical standards. Contact us today to learn more about our Strontium Ranelate offerings and how our stability testing capabilities can benefit your product development.